Vogenx, Inc. (VOGX) company profile
VOGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026
$13.48−0.90 (-6.26%)
Close on Nov 17, 2026Market cap $200.25MP/E –Yield –
About Vogenx
Pharmaceutical Preparations, SIC 2834
Vogenx, Inc. is listed on Nasdaq under the ticker VOGX, in the SEC industry Pharmaceutical Preparations. It is incorporated in Delaware and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2024.
Company profile
Company
- Legal name
- Vogenx, Inc.
- Headquarters
- Raleigh, NC
- Address
- 3901 Barrett Drive, Suite 300 27609
- Phone
- (919) 659-5677
- Website
- vogenx.com
- Industry
- Pharmaceutical Preparations
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- VOGX
- Exchange
- Nasdaq
- IPO date
- Aug 12, 2026
- Shares outstanding
- 15M, Sep 17, 2026
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 1903784
- CUSIP
- 92859A106
- ISIN
- US92859A1060
- FIGI
- BBG023PKT418
- Share class FIGI
- BBG023PKT5X0
- LEI
- 5299004KM33YCDWS6I69
- EIN
- 86-3697324
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| William Wilkison | Chief Scientific Officer, Director | 1,800,000 |
| James Green | Chief Executive Officer, Director | 1,800,000 |
| Steven R. Delmar | Chief Financial Officer, Director | 704,273 |
| Kenneth John Toombs | Director | – |
| Peter Pieraccini | Director | 42,735 |
| Timothy Boris | Director | – |
| Richard M. Gorman | Director | – |
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Aug 12, 2026
- Offer price
- $13.00
- Securities offered
- 6,250,000
- Gross proceeds
- $81.25M
- Exchange
- Nasdaq
- First trading day
- Aug 12, 2026
- First-day close
- $13.000.0%
- Lock-up ends (est.)
- Feb 8, 2027
“The initial public offering price is $13.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 12, 2026 | IPO | Initial public offering priced (424B4 prospectus) |
| Aug 10, 2026 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?